HGF and neoplasm: As HGF/cMET inhibits apoptosis and promotes immune tolerance by interacting with the programmed death ligand 1 (PD-L1) (Balan et al., 2015), the stimulation of this signaling pathway by NRP1 promotes tumor growth by inhibiting the antitumor immunity.